Home PACS News PACS Corporate News Trends in the Use of F-Fluorodeoxyglucose PET Imaging in Surveillance of Non—Small-Cell Lung and Colorectal Cancer
Trends in the Use of F-Fluorodeoxyglucose PET Imaging in Surveillance of Non—Small-Cell Lung and Colorectal Cancer PDF Print E-mail
Written by PACSMule Administrator   
Wednesday, 13 January 2016 17:00
Surveillance PET after curative-intent treatment of non–small-cell lung cancer (NSCLC) or colorectal cancer (CRC) is not clearly supported by available evidence or the Choosing Wisely campaign. However, the frequency of PET imaging during the surveillance period is relatively unknown.

Read more